Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05906719

Machine Vision Based MDS-UPDRS III Machine Rating

Conditions: Parkinsonian Disorders, Machine Learning

Sex: All
Ages: 20 Years – 80 Years
Healthy volunteers: No
Enrollment: 1679
Sponsor: Ruijin Hospital

Location: Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University Beijing Beijing Municipality

Summary

The Movement Disorders Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III (MDS-UPDRS III) is the primary assessment method for motor symptoms in Parkinson's disease patients. Currently, movement disorder specialists conduct semi-quantitative scoring, which entails limitations such as subjectivity, weak sensitivity, and a limited number of professional physicians. This study, based on machine vision, establishes gold standard labels according to expert scoring. By using machine learning, we develop a machine rating model and compare the model's performance with gold standard rating and general clinical rating to investigate the accuracy of machine vision-based MDS-UPDRS III machine rating.

Eligibility Criteria

Inclusion Criteria: * Meeting the diagnostic criteria for Parkinsonism established by the International Movement Disorder Society: having bradykinesia, and meeting at least one of the two criteria for resting tremor or muscle rigidity * 20 to 80 years old * Good compliance, voluntarily joining the study, and able to sign an informed consent form or have it signed by a legal representative Exclusion Criteria: * Significant cognitive impairment (MMSE ≤ 23) * Unable to sign written informed consent or unable to complete the trial due to other reasons * Other situations in which the researcher deems the participant unsuitable for this study * Participation in other clinical trials

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05906719). StuddyBuddy aggregates publicly available trial information.